Results 1 to 10 of about 2,383,672 (201)
Some of the next articles are maybe not open access.

Targeting BTK With Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2013
Jeff P Sharman   +2 more
exaly  

Ibrutinib as Initial Therapy for Patients With Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2015
Tanya Siddiqi, Anna Schuh, Peter Hillmen
exaly  

Targeting BCL2 With Venetoclax in Relapsed Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2016
John M Pagel   +2 more
exaly  

SF3B1 And Other Novel Cancer Genes in Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2011
Alexander R. Vartanov   +2 more
exaly  

Prognosis in Chronic Lymphocytic Leukemia

Ca-A Cancer Journal for Clinicians, 1961
exaly  

ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2003
Neus Villamor   +2 more
exaly  

Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2005
Kanti Rai   +2 more
exaly  

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2018
Peter Hillmen   +2 more
exaly  

Acute Myeloid Leukemia Management and Research in 2025

Ca-A Cancer Journal for Clinicians
Naval Daver   +2 more
exaly  

CRISPR/Cas9 in Chronic Lymphocytic Leukemia [PDF]

open access: yesEncyclopedia, 2022
Genome-editing systems such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology have uncovered new opportunities to model diseases such as chronic lymphocytic leukemia.
María Hernández-Sánchez
doaj   +2 more sources

Home - About - Disclaimer - Privacy